JAMDA
April 20, 2023
Showing 111 - 120 of 2381 results
JAMDA
December 28, 2020
To What Extent Do Local Nursing Home Prescribing Patterns Relate to Psychotropic Prescribing in Assisted Living?
In nursing homes (NHs), psychoactive medication use has received notable attention, but less is known about prescribing in assisted living (AL). This study examined how antipsychotic and antianxiety medication prescribing in AL compares with NHs.
JAMDA
October 6, 2021
Modest Association between Antibiotic and Antipsychotic Prescribing Rates in Nursing Homes
JAMDA
February 7, 2014
Point Prevalence of Risk: Combined Effects of Antipsychotics, Antidepressants, Anxiolytics, Narcotics and Sedative-hypnotics on Falls in a Nursing Home Long Term Care Unit. An Interdisciplinary Team Approach to Patient Safety and Quality Improvement
JAMDA
November 16, 2017
Efficacy and Safety of Citalopram Compared With Atypical Antipsychotics on Agitation in Nursing Home Residents With Alzheimer Dementia
JAMDA
July 21, 2017
Efficacy and Safety of Citalopram Compared to Atypical Antipsychotics on Agitation in Nursing Home Residents With Alzheimer Dementia
To assess efficacy and safety of citalopram compared to quetiapine and olanzapine for the treatment of agitation in patients with Alzheimer disease (AD).
JAMDA
February 26, 2020
Discontinuation of Antipsychotic Medication in Two Nursing Home Patients with Diagnosis of Schizophrenia
Caring for the Ages
September 29, 2022
Racial Disparities, Reimbursement for Care, and Quality of Life: Factors That May Influence the Prescribing of Antipsychotics for Minority Nursing Home Residents
JAMDA
September 26, 2018
Quality Clinical Care in Nursing Facilities
Despite improvements in selected nursing facility (NF) quality measures such as reduction in antipsychotic use; local, state, and national initiatives; and regulatory incentives, the quality of clinical care delivered in this setting remains inconsistent. Herein, recommendations for overcoming barriers to ...
JAMDA
July 20, 2021